These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19006382)
1. Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine. Yoo CB; Valente R; Congiatu C; Gavazza F; Angel A; Siddiqui MA; Jones PA; McGuigan C; Marquez VE J Med Chem; 2008 Dec; 51(23):7593-601. PubMed ID: 19006382 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505 [TBL] [Abstract][Full Text] [Related]
3. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971 [TBL] [Abstract][Full Text] [Related]
4. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. Chen M; Voeller D; Marquez VE; Kaye FJ; Steeg PS; Giaccone G; Zajac-Kaye M Int J Oncol; 2010 Oct; 37(4):963-71. PubMed ID: 20811718 [TBL] [Abstract][Full Text] [Related]
5. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075 [TBL] [Abstract][Full Text] [Related]
6. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer. Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643 [TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Ben-Kasus T; Ben-Zvi Z; Marquez VE; Kelley JA; Agbaria R Biochem Pharmacol; 2005 Jul; 70(1):121-33. PubMed ID: 15885659 [TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509 [TBL] [Abstract][Full Text] [Related]
10. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer. Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734 [TBL] [Abstract][Full Text] [Related]
11. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Chuang JC; Yoo CB; Kwan JM; Li TW; Liang G; Yang AS; Jones PA Mol Cancer Ther; 2005 Oct; 4(10):1515-20. PubMed ID: 16227400 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia. Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182 [TBL] [Abstract][Full Text] [Related]
13. A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation. Griffin PT; Niederhuth CE; Schmitz RJ G3 (Bethesda); 2016 Sep; 6(9):2773-80. PubMed ID: 27402357 [TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119 [TBL] [Abstract][Full Text] [Related]
15. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Billam M; Sobolewski MD; Davidson NE Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325 [TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281 [TBL] [Abstract][Full Text] [Related]
18. Preferential response of cancer cells to zebularine. Cheng JC; Yoo CB; Weisenberger DJ; Chuang J; Wozniak C; Liang G; Marquez VE; Greer S; Orntoft TF; Thykjaer T; Jones PA Cancer Cell; 2004 Aug; 6(2):151-8. PubMed ID: 15324698 [TBL] [Abstract][Full Text] [Related]
19. The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Herranz M; MartÃn-Caballero J; Fraga MF; Ruiz-Cabello J; Flores JM; Desco M; Marquez V; Esteller M Blood; 2006 Feb; 107(3):1174-7. PubMed ID: 16239434 [TBL] [Abstract][Full Text] [Related]